Heartburn Remedy May Help Treat Heart Failure - CME Teaching Brief� - MedPage Today
SUITA CITY, Japan, Sept. 25 -- Heart failure patients who added 30 mg of Pepcid (famotidine) to standard therapy significantly improved NYHA functional class and reduced plasma B-type natriuretic peptide levels compared with patients given 150 mg of teprenone.
In a prospective open-label study, the 25 patients assigned to Pepcid for 24 weeks also had significant improvement in blood pressure, left ventricular end diastolic volume, and left ventricular end systolic volume compared with patients in the teprenone group, wrote Masfumi Kitakaze, M.D., Ph.D., and colleagues form National Cardiovascular Center.
The results of the prospective study appeared to confirm results of a retrospective study, and both findings were published together in a single paper in the Oct. 3 issue of the Journal of the American College of Cardiology.
Posted by gruwell at September 26, 2006 4:33 AM | TrackBack